Angiogenesis Inhibition in the Treatment of Prostate Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|9|10|1070-1078

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.9, Iss.10, 2009-12, pp. : 1070-1078

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of αvβ3 integrin reduces angiogenesis, bone turnover, and tumor cell proliferation in experimental prostate cancer bone metastases

By Nemeth Jeffrey   Cher Michael   Zhou Zhao   Mullins Chadwick   Bhagat Sunita   Trikha Mohit  

Clinical and Experimental Metastasis, Vol. 20, Iss. 5, 2003-09 ,pp. : 413-420

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of androgen-responsive LNCaP prostate cancer cell tumor xenograft growth by dietary phenethyl isothiocyanate correlates with decreased angiogenesis and inhibition of cell attachment

By              

International Journal of Oncology, Vol. 40, Iss. 4, 2012-01 ,pp. : 1113-1121

Spandidos Publications

Access to resources Recommend Favorite

Inhibition of Angiogenesis as a Treatment Strategy for Neuroblastoma

By  

Current Cancer Therapy Reviews, Vol. 13, Iss. 1, 2017-08 ,pp. : 43-62

Bentham Science Publishers

Access to resources Recommend Favorite

Angiogenesis in Prostate Cancer: Biology and Therapeutic Opportunities

By Nicholson B.   Schaefer G.   Theodorescu D.  

Cancer and Metastasis Reviews, Vol. 20, Iss. 3-4, 2001-12 ,pp. : 297-319

Springer Publishing Company

Access to resources Recommend Favorite

Fasudil inhibits prostate cancer-induced angiogenesis in vitro

By  

Oncology Reports, Vol. 32, Iss. 6, 2014-01 ,pp. : 2795-2802

Spandidos Publications

Access to resources Recommend Favorite